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Abstract
 
In the thymus, several steps of proliferative expansion and selection coordinate the maturation
of precursors into antigen-specific T cells. Here we identify the transcriptional repressor Gfi1 as
an important regulator of this maturation process. Mice lacking Gfi1 show reduced thymic
cellularity due to an increased cell death rate, lack of proliferation, and a differentiation block in
the very early uncommitted CD4
 
 
 
/CD8
 
 
 
/c-Kit
 
  
 
cytokine-dependent T cell progenitors that
have not yet initiated VDJ recombination. In addition, Gfi1-deficient mice show increased ma-
jor histocompatibility complex class I–restricted positive selection and develop significantly
more CD8
 
  
 
cells suggesting a requirement of Gfi1 for a correct CD4/CD8 lineage decision.
Absence of Gfi1 correlates with high level expression of the genes for lung Krüppel-like factor
(LKLF), inhibitor of DNA binding (Id)1 and Id2, suggesting the existence of new regulatory
pathways in pre-T cell development and thymic selection in which Gfi1 acts upstream of LKLF
as well as the E-proteins, which are negatively regulated by Id1 and Id2.
 
Key words: zinc ﬁnger protein • T cell differentiation • apoptosis • lineage skewing • 
helix-loop-helix proteins
 
Introduction
 
Gfi1 is a 55-kD nuclear protein and a member of a protein
family that includes Gfi1b (1, 2) as well as the murine pro-
teins Snail and Slug (3, 4). All proteins of the Gfi1 family
share six carboxyterminal C
 
2
 
-H
 
2 
 
zinc finger domains and
the characteristic “SNAG” domain that comprises the first
amino terminal 20 amino acid residues (4). It has been
demonstrated that Gfi1 is able to bind to specific DNA tar-
get sequences in vitro and that DNA binding depends on
the presence of the zinc finger domains. Experiments with
reporter genes driven by synthetic promoters containing
Gfi1 binding sites suggested a transcriptional repressor ac-
tivity of Gfi1 (3, 4). An alternative activity of Gfi1 has been
discovered through its interaction with the protein inhibi-
tor of activated signal transducer and activator of transcrip-
tion (STAT) (PIAS)
 
*
 
3 (5). PIAS3 can bind to the activated
form of the latent STAT3 transcription factor and is able to
down-regulate the activity of STAT3 as a transcriptional
transactivator (6). By virtue of its interaction with PIAS3,
Gfi1 is able to relieve STAT3 from PIAS3-mediated inhi-
bition with the consequence of an enhanced STAT3 re-
sponse (5). This suggested a role of Gfi1 in a set of specific
cytokine-signaling pathways because STAT3 is activated in
response to a number of cytokines, among them IL-2, IL-6,
IL-10, or G-CSF.
A role of Gfi1 in cytokine or growth factor signaling had
already been suggested earlier because the Gfi1 gene was
found to be activated by proviral insertion in Nb2 rat lym-
phoma cell clones selected for IL-2–independent growth
after infection with Moloney murine leukemia virus (7).
Indeed, several studies with cultured cells indicated that a
constitutive Gfi1 expression can relieve peripheral mature
T cells from a requirement of IL-2 to overcome a G1 arrest
(3) or could help sustain cell proliferation of IL-2–depen-
dent cells in the absence of the cytokine (8), indicating a
role of Gfi1 in IL-2–dependent cell cycle progression of T
cells. Similarly, the Gfi1 gene is transcriptionally activated
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Abbreviations used in this paper: 
 
BrdU, bromo-deoxy-uridine; c-Maf,
bZIP transcription factor; DN, double negative; DP, double positive;
FTOC, fetal thymic organ culture; Id, inhibitor of DNA binding; ISP,
immature single positive; Lin, lineage; LKLF, lung Krüppel-like factor;
PIAS, protein inhibitor of activated signal transducer and activator of tran-
scription; SCF, stem cell factor; SP, single positive; STAT, signal trans-
ducer and activator of transcription; TRAF, TNFR-associated factor.T
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Altered Thymocyte Maturation in Gfi1
 
 
 
/
 
 
 
 Mice
 
by retroviral insertion in T lymphoid tumors that arise in
mice after infection with Moloney murine leukemia virus
(8–10). In addition, we have previously shown that Gfi1
acts as a dominant oncogene when overexpressed and co-
operates strongly with pim-1 and myc genes in T cell lym-
phomagenesis (11).
Gfi1 is expressed in T cell precursors from the early
stages of pre-T cell development up to the point when cells
express both CD4 and CD8 surface markers (12). In ma-
ture CD4 or CD8 single positive (SP) T cells, Gfi1 is absent
but rapidly up-regulated after TCR stimulation (5). The T
cell progenitors that lack CD4 and CD8 surface marker
(double negative [DN] cells) can be subdivided according
to the surface markers CD44 and CD25 (13). The earliest
precursor cells that enter the thymus from the bone mar-
row, which express CD44 (DN1) or CD44 and CD25
(DN2), are still uncommitted and depend on the presence
of cytokines such as stem cell factor (SCF; c-Kit ligand) and
IL-7 and the functionality of their respective receptors (14–
18). These cells can still develop into other lineages (Lins)
such as thymic dendritic cells, NK cells, and B cells, and
maintain an unrearranged germline configuration of all
TCR loci (16, 19). Therefore, deletion of both c-Kit and
IL-7R entirely block pre-T cell development beyond this
very early stage as well as the formation of a T cell reper-
toire. In contrast, deletion of only c-Kit or SCF or of the
IL-7R still allows the development of all T cell Lins albeit
at reduced rates (17, 20, 21).
The early CD44
 
  
 
CD25
 
  
 
(DN1) precursor cells up-reg-
ulate CD25 expression and start to proliferate in a first
wave of cytokine-dependent pre-T cell expansion and give
rise to the DN2 subset. When these cells enter G1/G0 and
start to rearrange their TCR
 
 
 
, TCR
 
 
 
, and TCR
 
  
 
chain
genes (22, 23), CD44 expression decreases to form the
CD25
 
 
 
/CD44
 
 
 
lo 
 
DN3 subset. This DN3 population is
proliferating as well as the main source of precursor cells
that populate the thymus. DN3 cells are subject to a process
called pre-TCR selection or “
 
  
 
selection” (13, 16, 24–26).
Only those DN3 cells that have productively rearranged
their TCR
 
  
 
chain gene segments survive this selection step
(“L cells”). CD25
 
 
 
/CD44
 
 
 
lo 
 
(DN4) cells, which directly
emerge from DN3, express functional TCR
 
  
 
chains and
are termed “
 
  
 
selected” (26, 27). They quickly up-regulate
the surface markers CD4 and CD8 and give rise to the ma-
jor double positive (DP) T cell population of the thymus
(28, 29). High levels of constitutively expressed Gfi1 can
inhibit the passage of DN3 cells that have not yet com-
pleted VDJ recombination (“E cells”) to L cells during
 
  
 
selection, suggesting a role of Gfi1 in this process (12).
Once DN cells up-regulate the CD4 and CD8 surface
markers and express functional 
 
 
 
/
 
  
 
TCR molecules, a
process called positive/negative selection ensures the elimi-
nation of self-reactive T cells and the propagation of self-
tolerant T cells (30–32). Positive/negative selection over-
laps with CD4/CD8 Lin decision leading to the exclusive
expression of either CD4 on MHC class II– or CD8 on
MHC class I–restricted T cells, respectively.
 
Here we show that Gfi1
 
    
 
mice have a severely de-
creased thymic cellularity due to defects in cell survival and
proliferation of the very early DN1 and DN2 c-Kit
 
  
 
pre-T
cells associated with a block of differentiation from DN1
cells into the DN2 stage and a reduced DN3 population.
We also show accelerated passage from E to L cells during
pre-TCR selection. In addition, Gfi1 deficiency is associ-
ated with accelerated positive selection of MHC I–restricted
DP thymocytes and seems to affect the CD4/CD8 Lin de-
cision. Finally, the disruption of thymic T cell maturation
in mice lacking Gfi1 is associated with the deregulated ex-
pression of a restricted set of effector genes, among them
the helix-loop-helix transcription factors inhibitor of DNA
binding (Id)1 and Id2 (33).
 
Materials and Methods
 
Generation of Gfi1-deficient Mice.
 
Gfi1-deficient mice were
generated by homologous recombination in R1 embryonic stem
cells. Transfection of embryonic stem cells and selection of
clones was performed essentially as previously described (34).
Mice were housed at the animal facility of the University of Es-
sen Medical School in single ventilated cages under specific
pathogen-free conditions. Mice that were used for analyses were
healthy 4–6-wk-old animals from an 8–10 generation backcross
with C57BL/6 animals.
 
Antibody Staining Procedures and Cell Cycle Analysis.
 
Single
cell suspensions were prepared as previously described (35) at the
time of autopsy from the thymus or spleen in PBS supplemented
with 0.5% FCS (staining solution). Cell numbers were calculated
using a CASY-1 cell counter (Schärfe System). Cells were washed
in this solution and incubated at 4
 
 
 
C for 30 min with antibodies
directly conjugated with fluorochromes. Cells were washed twice
in staining solution after the incubation and examined with a
FACSCalibur
 
® 
 
(Becton Dickinson). To analyze the DN popula-
tion, Lin marker negative cells (Lin
 
 
 
) were selected by staining
thymocytes with the biotinylated antibodies against CD3, CD4,
CD8, B220, Gr-1, Mac-1, Ter-119, and DX5 followed by
streptavidin-PerCP or –tri-color and APC- or PE-labeled anti-
CD25 and FITC- or PE-labeled anti-CD44. PerCP or tri-color–
negative cells (Lin
 
 
 
) were analyzed for expression of CD44 versus
CD25. Staining for intracellular TCR
 
  
 
chains was performed as
previously described (36). Antibodies against TCR
 
  
 
and TCR
 
 
 
chain subtypes and all tri-color–conjugated antibodies were pur-
chased from Medac, antibodies against 
 
 
 
/
 
  
 
TCR and CD62L
were obtained from Immunotech, and all other antibodies used in
FACS
 
® 
 
analysis were from BD Biosciences. For the cell cycle
analysis, thymocytes were stained as described above, washed, and
then incubated in 2 
 
 
 
g/ml Hoechst 33382 (Sigma-Aldrich) in
PBS for 30 min at 37
 
 
 
C. FACS
 
® 
 
analysis on the gated DN subsets
was performed by flow cytometry with an ultra violet laser at 424
nm. For the detection of apoptotic cells, an annexin V staining kit
from BD Biosciences was used according to the manufacturer’s
instructions.
 
Bromo-deoxy-uridine (BrdU) Incorporation.
 
Three groups of six
mice (three WT and three Gfi1
 
 
 
/
 
  
 
for each group) were initially
injected intraperitoneally with 1.8 mg/200 
 
 
 
l BrdU (Roth) in sa-
line and then continuously given BrdU at 1 mg/ml in the drink-
ing water that was changed daily. At different time points (24, 48,
and 72 h), three WT and three Gfi1
 
 
 
/
 
  
 
animals were killed and
their thymi were removed. Thymocytes were first stained for ex-T
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tracellular markers and then washed, fixed, and stained again with
FITC-conjugated anti-BrdU antibodies (Caltag) using the Cyto-
fix/Cytoperm kit (BD Biosciences) according to the manufac-
turer’s instructions.
 
Fetal Thymic Organ Culture (FTOC).
 
Pregnant mice were
killed at day 13 after coitum and fetal thymi were prepared and
incubated on isopore membranes (0.8 
 
 
 
m ATTP; Millipore) that
had been equilibrated on FTOC medium (95% medium-119, 5%
FBS, 1,000 U penicillin/streptomycin) for 1 h. Incubation of
FTOC was performed at 5% CO
 
2 
 
for 5 d. The medium was
changed after a period of 2 d. Typical cell recovery was between
2.5 and 3 
 
  
 
10
 
4 
 
cells per lobe.
 
DNA Array Analysis.
 
Total RNA from thymocytes was used
without enrichment of the polyA
 
  
 
fraction to prepare a labeled
RNA target as previously described (37). In brief, the RNA was used
to synthesize a single stranded cDNA via oligo dT priming and RT.
The cDNA was made double stranded and then transcribed into a
cRNA in an in vitro transcription reaction. The in vitro transcription
reaction results in a linear amplification of the mRNA molecules
originally isolated. This target RNA was hybridized to the Murine
11K Affymetrix high density DNA probe array. Signal intensities for
the known and defined genes in this array omitting the EST se-
quences were recorded with the Microarray Suite 4.0 Software.
 
RT-PCR.
 
RT-PCR was performed as previously described
(38). In brief, DP thymocytes were sorted by FACSVantage™
and DN and CD8
 
  
 
thymocytes were isolated by using magnetic
beads on autoMACS (Miltenyi Biotec). RNA was prepared with
the use of RNeasy Kit (QIAGEN) according to the manu-
facturer’s instructions. The synthesis of cDNA was performed as
described above. The sequences of primers used are as follows:
Id1 sense, 5
 
 
 
-TCAGGATCATGAAGGTCGCCAGTG-3
 
 
 
; Id1
antisense, 5
 
 
 
-TGAAGGGCTGGAGTCCATCTGGT-3
 
 
 
; Id2
sense, 5
 
 
 
-TCTGAGCTTATGTCGAATGATAGC-3
 
 
 
; Id2 anti-
sense, 5
 
 
 
-CACAGCATTCAGTAGGCTCGTGTC-3
 
 
 
; 
 
  
 
actin
sense, 5
 
 
 
-TCCTGTGGCATCCATGAAACT-3
 
 
 
; and 
 
  
 
actin
antisense, 5
 
 
 
-GAAGCACTTGCGGTGCACGAT-3
 
 
 
.
 
Results
 
Gfi1-deficient Mice Have Low Thymic Cellularity and a Bias
toward the Development of CD8 SP Cells.
 
The generation
of Gfi1-deficient mice has been described elsewhere (34).
Animals were generated in a mixed F1 (129
 
 
 
C57BL/6)
background and then backcrossed with C57BL/6 mice for
six to eight generations. All mice used in this study were
healthy animals from this intercross held under specific
pathogen-free conditions at 4–6 wk of age except when
otherwise indicated. The thymi of Gfi1-deficient (Gfi1
 
 
 
/
 
 
 
)
mice were very small and total cell numbers were reduced
on average to only 10% of levels found in WT or Gfi1 het-
erozygous animals (Gfi1
 
 
 
/
 
 
 
; Fig. 1 A) whereas histological
sections revealed a largely normal thymic architecture (un-
published data). Accordingly, the absolute numbers of the
DN, DP, and SP populations and of 
 
 
 
/
 
  
 
TCR– and 
 
 
 
/
 
 
 
TCR–bearing T cells were significantly reduced in Gfi1
 
 
 
/
 
 
 
mice compared with WT controls (Fig. 1, B and C). The
relative numbers of DP cells were decreased whereas DN
and CD4
 
  
 
SP cell frequencies remained unchanged in
Gfi1
 
 
 
/
 
  
 
mice (Fig. 1 D). However, the ratio of CD4 to
CD8 percentages were altered in favor of the CD8 SP
 
population from 4:1 in WT to equal levels (1:1) in Gfi1-
deficient mice (Fig. 1 D). An additional CD4
 
 
 
/CD8
 
lo
 
population was detected in Gfi1-deficient animals that is
absent from the corresponding WT control (Fig. 1 D,
small round gate).
To test whether the higher percentage of CD8
 
  
 
cells was
due to an overrepresentation or a delayed development of
immature CD8 SP cells, we analyzed electronically gated
CD8
 
  
 
cells from six individual WT and six individual
Gfi1-deficient mice for the expression level of CD3. Im-
mature SP (ISP) cells bear low levels of CD3 whereas ma-
ture selected CD8
 
  
 
cells express high levels. We find the
same percentages of CD8
 
  
 
CD3
 
hi 
 
and CD8
 
  
 
CD3
 
lo 
 
popula-
tions in WT as in Gfi1-deficient mice (Fig. 1 E) excluding
overrepresentation of ISP cells in Gfi1 KO mice.
Expression of different variable TCR chains (V
 
 
 
8, V
 
 
 
4,
V
 
 
 
7, V
 
 
 
8.2, V
 
 
 
10, and V
 
 
 
12b) was generally detected on
thymocytes of Gfi1
 
 
 
/
 
  
 
mice (unpublished data) suggesting
that the lack of Gfi1 does not affect VDJ recombination dur-
ing or after pre-TCR selection nor grossly alters the TCR
repertoire. Moreover, spleen and lymph nodes of Gfi1
 
 
 
/
 
 
 
animals contained mature T cells indicating that the loss of
Gfi1 does not generally affect T lymphocyte homing nor exit
from the thymus (unpublished data). The low thymic cellu-
larity, the bias toward CD8
 
  
 
cells, and the emergence of a
new CD4
 
 
 
/CD8
 
lo 
 
population could be reproduced in
mixed bone marrow chimeras by transplantation of Gfi1
 
 
 
/
 
 
 
cells (unpublished data). This indicated that the phenotype of
Gfi1-deficient thymocytes is intrinsic and cell autonomous.
 
Gfi1 Deficiency Negatively Affects the Generation of CD4 SP
Cells and Accelerates MHC I–restricted Positive Selection of
CD8 SP Cells.
 
To analyze in more detail the effect of
Gfi1 deficiency on the ratio of CD4/CD8 cells, we have
used the activation marker CD69, which is transiently ex-
pressed during the selection process and discriminates be-
tween cells before and after positive/negative selection
(39). To distinguish between different maturation stages of
DP and SP cells, we have stained thymocytes from both
WT and Gfi1
 
 
 
/
 
  
 
mice with CD4, CD8, CD69, and
TCR  expression and analyzed the cells with four-color
flow cytometry (40). This defined five sequential matura-
tion stages: R2: TCR   CD69 ; R3: TCR int CD69 ;
R4: TCR int  CD69 ; R5: TCR hi  CD69 ; and R6:
TCR hi CD69  (Fig. 2 A). This analysis showed that the
percentages of TCR hi CD69  cells are reduced from 13%
in WT mice to 5% in Gfi1null mice (Fig. 2 A, R5) whereas
the relative percentages of TCR int CD69  cells remained
unchanged (Fig. 2 A, R4). In accordance with previously
published experiments, CD4  cells appear before CD8 
cells (Fig. 2 A, R4 and R5). In Gfi1-deficient mice, this se-
quential appearance seems to be unaffected but the relative
proportion of CD4  SP cells is decreased from 17 to 8% in
R4 and from 69 to 40% in R5 compared with WT mice
(Fig. 2 A). This suggests that during and after selection, the
ratio of CD4/CD8 percentages is continuously altered in
Gfi1 /  mice in favor to the CD8  compartment (Fig. 2 A,
R4, R5, and R6). An even more pronounced situation wasT
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found in FTOC experiments of d13 fetal thymocytes
where CD4 SP cells were almost completely absent in
thymi from Gfi1-deficient mice after 5 d of culture (Fig. 2
B) and in the IL-7R   subpopulation of freshly isolated
thymocytes where CD8 SP cells are also overrepresented.
(Fig. 2 C). In addition, percentages of cells positive for the
IL-7R  chain were found to be significantly higher in DP
and in CD8 SP subsets of Gfi1 /  mice than in the same
subsets of WT mice (Fig. 2 D). The expression level of IL-
7R  chain itself was similar in WT and Gfi1 /  DP and SP
subsets (Fig. 2 D).
In the next step, we examined whether the lack of Gfi1
would directly affect positive selection of DP thymocytes.
We crossed Gfi1 /  mice with animals expressing a trans-
genic T cell receptor recognizing the male specific HY an-
tigen, which is presented by MHC I (41). Due to allelic
exclusion, nearly all T cells of HY-TCR transgenic mice
carry the T cell receptor directed against the HY antigen.
Therefore, male mice that express this antigen delete DP
cells because the HY-TCR is self-reactive. In female WT
mice that lack the HY-antigen, the positive selection of DP
cells to CD8  SP cells is enhanced resulting in an increased
relative proportion of CD8 SP cells of  21% (Fig. 3 A)
compared to WT mice that display around 3% CD8  cells
(Fig. 1 D). In female Gfi1 / /HY-TCR mice, the per-
centage of CD8 SP cells strongly increased from 21 to 49%
of all thymocytes and from 26 to 50% on thymocytes se-
lected for the expression of the HY-TCR V 3 chain (de-
tected with the clonotypic monoclonal T3.70 antibody;
Fig. 3 A). The compiled analysis of four individual WT and
four individual Gfi1-deficient mice showed 22.7% ( 3.5)
CD8  T3.70  cells versus 41.3% ( 5.6), respectively (Fig.
3 B). This overrepresentation of CD8  SP cells is also evi-
dent when only the T3.70  CD69  subset is analyzed (Fig.
Figure 1. Gfi1 /  mice show impaired thymocyte de-
velopment and reduced thymic cellularity. (A) Absolute
thymocyte numbers from Gfi1-deficient mice ( ) are
reduced compared with those from their WT ( ) or het-
erozygous littermates ( ). The average cell number is indi-
cated by a solid line. (B and C) Thymocytes from 4–6-wk-
old WT, Gfi1 / , and Gfi1 /  mice were isolated, stained
with anti-CD4, anti-CD8 antibodies, or with antibodies
recognizing TCR  chain or  /  chains and were analyzed
by flow cytometry. Absolute numbers of all four CD4/
CD8 subsets and of TCR-bearing cells representative of
several animals are documented. (D) Cytofluorimetric
analysis showing the relative percentages of cells bearing
CD4 or CD8 surface markers of normal control littermates
(left) and Gfi1-deficient mice (right). The percentage of
CD8 SP cells is increased from 3 to 11% whereas the per-
centage of CD4 SP cells remained unchanged in Gfi1 / 
mice. In addition, the percentage of DP cells is decreased
to 73% in the absence of Gfi1 and a new CD4  CD8lo
population appears in Gfi1 /  mice (round gate). These al-
terations are consistently found in all analyses. Representa-
tive examples of  10 6-wk-old animals for each genotype
are shown. (E) Flow cytometric analysis of CD3 expression
of electronically gated CD8  cells of both WT and Gfi1null
mice. A representative histogram for each subset and com-
piled percentages of CD3 - and CD3 /lo-expressing cells
is shown. The number represents means with standard de-
viations from six individual WT and six individual Gfi1-
deficient mice. The dotted line represents WT animals and
the dark line represents the Gfi1-deficient cells.T
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3 C). Both CD8  cells and total thymocytes from Gfi1-
deficient HY-TCR or WT HY-TCR transgenic mice ex-
pressed identical peak levels of the HY-TCR V 8 and
V 3 chains (Fig. 3 D) excluding a perturbation of the HY-
TCR expression in Gfi1 /  mice. Strikingly, the percent-
age of CD8  or total thymocytes expressing high levels of
HY-TCR   and   chains was almost 100% in HY-TCR
females negative for Gfi1, which represents a significant in-
crease over HY-TCR animals with intact Gfi1. In contrast,
the deletion of DP cells through negative selection was ef-
fective in male HY-TCR, leading to a reduction of total
thymocyte numbers to 8   105 cells of which the majority
(81%) lack CD4 or CD8 surface markers (Fig. 3 E). In HY-
TCR/Gfi1 /  mice the total number of thymocytes was
reduced to about the same number (8.5   105) but ele-
vated percentages of DP (6%), CD4 SP (29%), or CD8 SP
(16%) cells were observed with regards to HY-TCR ani-
mals with intact Gfi1 expression (Fig. 3 E).
To gain more insight into the mechanism of how the
loss of Gfi1 affects positive selection we have measured
BrdU incorporation over a period of 3 d into different thy-
mocytes subsets. For each time point, we have analyzed
three individual control mice and three individual Gfi1 KO
mice. Cell populations bearing the CD4 or CD8 corecep-
tors were gated according to Germain (reference 42; Fig. 4
B) and analyzed for BrdU incorporation. We could not de-
tect significant differences between the proliferation rate of
normal mice and Gfi1-deficient animals in the CD4 
CD8  (DN) and CD4  CD8  (DP) subsets, nor in the
CD4lo CD8  and CD8  (SP) populations (Fig. 3 F and un-
published data). This excludes that the higher relative per-
centages of CD8  cells that we see in Gfi1 /  mice are due
to a higher proliferation rate. In contrast, we discovered
that the CD4lo  CD8lo  and CD4  CD8lo  populations in
Gfi1 /  mice had a significantly lower proliferative poten-
tial compared with the respective WT populations (Fig. 3
F). Because the CD4lo CD8lo and CD4  CD8lo subsets still
bear the potential to develop into both CD4 and CD8 Lins
(42), we can again exclude that the higher percentages of
CD8  cells in the Gfi1 /  mice is due to a higher prolifera-
tion rate of these precursor cells.
Gfi1  Mice Lose Cells of the Proliferating DN/c-Kit  Subset
Due to an Increased Cell Death Rate and a Lower Proliferative
Capacity. Another hallmark of Gfi1-deficient mice is their
reduced thymic cellularity (Fig. 1 A). Because the expan-
sion or deletion of particular T cell precursor subsets in the
thymus relies on the regulation of cell proliferation and cell
death, we analyzed forward/sideway scatter profiles of all
thymic lymphoid cells. In Gfi1null mice a high percentage of
cells with lower values of both parameters were detected
suggesting significantly elevated numbers of dead cells (Fig.
4 A). To determine the extent of cell death initiated in
Gfi1 /  mice, apparently intact cells were sorted (Fig. 4 A,
R1) and analyzed for the presence of phosphatidylserine on
the cell surface (by annexin V staining) and for propidium
iodide uptake. The analysis of total thymocytes or the re-
spective DN, DP, or SP subsets revealed no or only a mod-
erate increase of dead or dying cells in Gfi1null mice com-
Figure 2. Gfi1 /  mice show an imbalance of CD4 and CD8 SP cells
in positively selected subsets and show altered IL-7R  expression in DN
subsets. (A) Thymic subpopulation defined by the expression of CD69
and the TCR  chain. Total thymocytes were stained for the presence of
CD69, TCR , CD4, and CD8 and were analyzed by four-color flow cy-
tometry. Gates in the CD69/TCR  analysis are indicated (left, R2–R6).
The subsets R2–R6 were reanalyzed for CD4 and CD8 expression
(right). Relative percentages of cells are depicted as insets. The analysis
was performed on four independent sets of Gfi1-deficient (Gfi1 / ) and
WT (Gfi1 / ) animals. (B) Two-color analysis of CD4- and CD8-stained
cells from d13 fetal thymi after 5 d in culture showing a dramatically re-
duced number of CD4 SP thymocytes in cultures from Gfi1-deficient
mice ( / , n   4 and  / , n   5). (C) Three-color flow cytometric
analysis of CD4 and CD8 expression gated on IL-7R   thymocytes. A
significant decrease of relative percentages of CD4 SP cells and a relative
increase of the CD8 SP population can be observed in Gfi1 /  mice
compared with the WT control in all cases. All analyses are representative
for at least six individual sets of animals. (D) Three-color analysis of IL-7R 
chain expression gated on DP and CD4 or CD8 SP cells. Thin lines indi-
cate the WT ( / ) control animal and the thick line represents the Gfi1-
deficient mouse ( / ).T
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836 Altered Thymocyte Maturation in Gfi1 /  Mice
pared with WT controls (unpublished data) excluding a
general effect of Gfi1 on the survival of all thymocyte sub-
sets. In addition, we found no altered susceptibility toward
induced apoptosis using various stimuli in vitro (unpub-
lished data). Next, we stained thymocytes for CD4 and
CD8 expression to analyze different subsets and found that
the CD4lo CD8lo subset in Gfi1null mice contained signifi-
cantly higher percentages of annexin V  cells than the cor-
responding population in WT controls (Fig. 4 B). The
compiled data for four individual pairs of mice showed val-
ues of 26% ( 5) for WT mice and 39% ( 6) for Gfi1null
mice. In addition, a significant increase of annexin V  cells
was observed when electronically gated c-Kit  cells from
Gfi1-deficient thymi were analyzed. The percentage of an-
nexin V  cells among the c-Kit  population rose from 8%
in WT mice to 33% in Gfi1-deficient animals (Fig. 4 C).
Introduction of a Bcl-2 transgene that is active in the earli-
est DN T cell progenitors (E -Bcl-2; reference 43) re-
duced the percentage of annexin V  c-Kit  cells back to
3%, similar to the levels found in single E  bcl-2 transgenic
mice (Fig. 4 C). However, the overall thymic cellularity of
Gfi1null mice could only marginally be elevated by the pres-
ence of Bcl-2 (Fig. 4 D).
To identify the c-Kit  subset that is affected by apoptosis
in Gfi1-deficient mice, we stained thymocytes for Lin
markers (CD3, CD4, CD8, Pan-NK, Gr-1, B220, Mac-1,
and Ter-119) or only for CD4, CD8, and c-Kit expression.
In a normal thymus (Gfi1 / ), 1.6% of the cells are Lin /
c-Kit  whereas only 0.2% of Lin  cells express c-Kit in the
Gfi1null mice (Fig. 4 E). As for the total c-Kit  population,
Figure 3. Lack of Gfi1 alters
MHC class I–restricted positive
selection. (A) Flow cytometric
analysis of CD4 and CD8 ex-
pression of total or T3.70  thy-
mocytes from female WT
(Gfi1 / ) or Gfi1 /  mice ex-
pressing the HY-TCR trans-
gene. Total thymocyte numbers
and the percentages of the re-
spective DN, DP, and SP cells
are indicated. Experiments are
representative for five different
sets of mice. (B) Compilation of
percentages of CD8 /T3.70 
cells from seven female Gfi1 / 
HY-TCR animals (open bar)
and from seven female Gfi1 / 
HY-TCR animals (solid bar).
(C) CD69 /T3.70  thymocytes
from female WT (Gfi1 / ) or
Gfi1 /   mice expressing the
HY-TCR transgene. Total thy-
mocyte numbers and the per-
centages of the respective DN,
DP, and SP cells are indicated.
Experiments are representative
for five different sets of mice. (D)
CD8   or total thymocytes of
both HY-TCR transgenic mice
and Gfi1 /  carrying the HY-
TCR transgene were analyzed
with an antibody against the
V 8.2 or the V 3 variable chain
of the HY-TCR. The V 3
chain was detected with the
T3.70 clonotypic antibody. (E)
Flow cytometric analysis of CD4
and CD8 expression on thy-
mocytes from 8-wk-old male
WT (Gfi1 / ) or Gfi1 /  mice
expressing the HY-TCR trans-
gene. Total thymocyte numbers
and the percentages of the re-
spective DN, DP, and SP cells
are indicated. (F) Three WT and
three Gfi1null mice were analyzed
for BrdU incorporation for each
time point over a period of 3 d. The indicated cell subsets were analyzed by flow cytometric measurements and the percentages of BrdU  cells were de-
termined. Values are means with standard deviations and are plotted against the time in days (d).T
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the percentage of annexin V  cells among Lin  c-Kit  cells
is increased from 9% in the WT mouse to 18% in Gfi1null
mice (Fig. 4 E). In addition, when the CD4/CD8 profile
of c-Kit  cells was analyzed we found that the c-Kit 
CD4  CD8  (DN) subpopulation is strongly decreased in
Gfi1-deficient mice to 19 from 89% in the respective WT
population (Fig. 4 F). This suggests that loss of Gfi1 leads to
a strong depletion of c-Kit–expressing cells in the Lin  or
CD4/CD8 DN subset. Coexpression of a bcl-2 transgene
could rescue this depletion partially to 49% (Fig. 4 F).
Loss of Gfi1 Causes Defects in DN1 and DN2 Thymocyte
Subsets That Affect Survival and Proliferation. In the next
step we wished to more closely analyze the effect of Gfi1
deficiency on the Lin  subpopulation. Lin  cells are also
termed DN cells and form four subsets according to the
relative expression of CD44 and CD25 surface markers
designated DN1, DN2, DN3, and DN4 reflecting their de-
velopmental stage (refer to Introduction). When Lin  cells
were analyzed for the presence of CD25 and CD44, we
observed that in Gfi1 /  mice, the relative percentages of
DN2, DN3, and DN4 cells were decreased compared with
the respective WT subsets (Fig. 5 A) and, most strikingly,
that a new population of CD44hi CD25int cells emerges in
Gfi1 /  mice, which accounts for up to 24% of the DN
compartment (Fig. 5 A, arrowhead). A similar accumula-
tion of CD44hi CD25int cells was observed in d13 fetal thy-
Figure 4. Cell survival and prolif-
eration is disturbed in Gfi1 /  mice.
(A) Thymocytes of Gfi1 /  mice ( / )
and WT controls ( / ) were analyzed
on forward/sideward scatter for mor-
phology and apparently intact cells
were gated (R1). (B) Thymocytes of
Gfi1 /  mice ( / ) and WT controls
( / ) were stained for CD4, CD8,
and annexin V and gated according to
Germain (reference 42) in seven sub-
sets, which are schematically depicted.
The subsets were electronically se-
lected and analyzed for annexin V
binding gated in forward/sideward
scatter on R1. Histograms for the
CD4lo  CD8lo  thymocyte population
from WT (Gfi1 / ) or Gfi1-deficient
(Gfi1 / ) mice are shown. (C) Thy-
mocytes were stained with annexin
V–FITC and c-Kit–PE and gated in
forward/sideward scatter on R1. The
percentages of c-Kit  thymocytes that
are able to bind annexin V–FITC for
Gfi1 /  mice ( / ), WT controls
( / ), E  bcl-2 transgenic mice or
double mutants lacking Gfi1 and ex-
pressing the Bcl-2 transgene (Gfi1 / ,
E  bcl-2) are depicted. (D) Compari-
son of the total number of thymocytes
of Gfi1 /  (WT controls), Gfi1 / 
mice, E  bcl-2 animals, and combi-
natorial mutant mice lacking Gfi1 and
bearing the E   bcl-2 transgene
(Gfi1 / , E  bcl-2). (E) Thymocytes
from WT (Gfi1 / ) or Gfi1 /  mice
were stained with antibodies against
Lin markers and for c-Kit expression
and analyzed by three-color flow cy-
tometry for annexin V binding (rep-
resentative for n   4 WT and n   4
Gfi1 /  mice). (F) Thymocytes from
WT (Gfi1 / ) or Gfi1 /  mice were
stained for CD4, CD8, and c-Kit ex-
pression and were analyzed by three-
color flow cytometry. The analysis
shows CD4 and CD8 expression on
electronically selected c-Kit  cells. In
particular, DN cells are depleted of
c-Kit  cells in the Gfi1 /  mice. All
datasets are representative of four to
five independent experiments with
individual mice.T
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838 Altered Thymocyte Maturation in Gfi1 /  Mice
mocytes from Gfi1 /  animals after 5 d in culture (unpub-
lished data). Cells of these new populations lack NK1.1,
 /  TCR, Mac-1, Gr-1, CD19, or CD11c but expressed
Thy 1.2 (unpublished data) and therefore are to be consid-
ered to belong to the T cell progenitor pool.
We have used four-color flow cytometry to analyze the
percentage of apoptotic cells among the different Lin  pop-
ulations and found that the DN1 and DN2 subsets in par-
ticular have significantly more cells that are annexin V  in
Gfi1null mice than in WT controls (Fig. 5 B). All other sub-
sets such as the DN3, DN4, or the new CD44hi CD25int
cells did not show significant differences with respect to an-
nexin V staining whether Gfi1 was present or not (Fig. 5
B). Next, we stained Lin  thymocytes from both types of
mice for CD25, CD44, and c-Kit expression and found
that cells of the DN1 and DN2 subsets in Gfi1null mice lack
c-Kit expression (Fig. 5 C). Also, the novel CD25int
CD44  population almost entirely lacked c-Kit  cells (Fig.
Figure 5. Depletion of c-Kit  cells and alter-
ations of DN subpopulations in Gfi1 /  mice. (A)
Flow cytometric analysis of CD25 and CD44 ex-
pression among electronically gated Lin negative
(Lin ) thymocytes. Relative percentages of DN2,
DN3, and DN4 cells appear to be altered in Gfi1 / 
mice compared with normal (Gfi1 / ) controls and
the emergence of a new population is noted (ar-
rowhead, CD44hi CD25int; n   10 for each geno-
type). (B) Thymocytes from WT (Gfi1 / ) or
Gfi1 /  animals were stained for expression of Lin
markers CD44 and CD25. Lin  cells and the indi-
cated subsets were analyzed for annexin V binding.
The gates for the DN subsets were as indicated in
A. The percentage of annexin V  cells for the indi-
cated subsets is given. The analysis reveals that only
the DN1 and DN2 subsets of Gfi1null mice contain
significantly more apoptotic cells (n   9 for each
genotype). The mean values for Gfi1-deficient and
WT DN1 cells are 16.8   4.8% and 9.1   3.5%,
respectively. This difference is significant at the 0.05
level (P   0.004). The mean values for Gfi1-defi-
cient and WT DN2 cells are 13.3   3.3% and 6.0  
2.9%, respectively. This difference is significant
at the 0.05 level (P   0.001; Student’s t test). (C)
Lin  thymocytes from WT (Gfi1 / ) or Gfi1 / 
mice were stained for CD44, CD25, and c-Kit ex-
pression. The percentage of c-Kit  cells is given for
the DN1, DN2, and CD25int CD44hi subset in WT
and Gfi1null mice (n   5 for each genotype). (D)
Lin  thymocytes from WT (Gfi1 / ) or Gfi1 / 
mice were stained for CD44, CD25, and IL-7R 
expression. The percentage of IL-7R    cells is
given for the DN1, DN2, DN3, DN4, and CD25int
CD44hi subset in WT and Gfi1null mice (n   4 for
each genotype). (E) Three WT and three Gfi1null
mice were analyzed for BrdU incorporation for
each time point over a period of 3 d. The indicated
cell subsets were analyzed by flow cytometric mea-
surements and the percentages of BrdU  cells were
determined. Values are means with standard devia-
tions and are plotted against the time in days (d).T
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5 C) but contained a significantly higher percentage of IL-
7R   cells (Fig. 5 D). The percentages of IL-7R   cells
was similar in WT and Gfi1 /  mice in all other DN sub-
sets except for DN1 where a slight increase was observed in
Gfi1null mice (Fig. 5 D).
To gain more insight in the effect of Gfi1 on the pro-
liferative behavior of thymocytes, we have followed
BrdU incorporation by flow cytometry over a period of
3 d in different Lin  subpopulations. For each time point,
we have analyzed three individual control mice and three
individual Gfi1null  mice. Cell populations bearing the
CD25 or CD44 markers were gated as depicted in Fig. 5
A. We found that the new intermediate cell population
expressing CD44hi CD25int that appears in Gfi1 /  mice
(Fig. 5 A) proliferates much less in the Gfi1 KO than the
corresponding cells in WT mice (Fig. 5 E). The DN3
subset is slightly more proliferative in the Gfi1 Ko than in
the WT control. The proliferation rate of all other Lin 
subsets such as the DN1, DN2, or DN4 population do
not differ significantly between Gfi1null and WT mice
(unpublished data).
Gfi1 Affects Processes Associated with Pre-TCR Selection.
A critical step in the differentiation of DN cells is the pre-
TCR selection that takes place in the DN3 subset (refer to
Introduction). When DN3 cell were analyzed for their size
distribution, we found that the relative frequency of larger
L cells that have undergone pre-TCR selection are over-
represented in Gfi1 /  mice. In WT DN cells this popula-
tion amounts to  14.9% ( 0.2) but in Gfi1-deficient DN3
cells the L cell subset rises to 23.4% ( 2.6). BrdU incorpo-
ration experiments demonstrated that the DN3 population
of Gfi1 /  mice has a slightly higher proliferative capacity
than the WT DN3 subset (Fig. 5 E). To test whether this
effect led to uncontrolled formation of DP cells we ana-
lyzed DN3 cells in Gfi1 / /RAG-1 /  mice. In normal
RAG-1 /  with intact Gfi1, no DP cells are formed and
the L subset percentage is limited to  3–4% of DN3 cells
due to the lack of TCR  chain expression (Fig. 6 A; refer-
ence 44). In contrast, Gfi1 / /RAG-1 /  DN3 cells con-
tained  14% L cells (Fig. 6 A), confirming the finding in
Gfi1 /  mice. To test whether this observed effect on the E
to L cell transition is associated with enhanced productive
(in frame) rearrangements of the TCR  locus, we mea-
sured the amount of intracellular TCR  chains in Gfi1 
DN3 cells. To this end, Lin  thymocytes were stained with
antibodies against Lin markers and CD25 and CD44. The
cells were then fixed and stained for cytoplasmic TCR 
according to described procedures (36). DN3 and DN4
cells from both WT and Gfi1 /  mice were electronically
gated and showed very similar percentages of cells with
identical cytoplasmic TCR  expression levels (Fig. 6 C)
suggesting that the lack of Gfi1 solely affects the regulation
of cell size among the E and L type DN3 subsets or the ex-
pansion of the L subset but does not alter the efficiency of
VDJ recombination nor the production of TCR  chains
from rearranged alleles.
Figure 6. Gfi1 deficiency disturbs passage
through pre-TCR selection but does not affect
VDJ recombination. (A) Analysis of the DN3
subset of mice with the indicated genotypes for
cell size distribution by forward angle light scat-
tering (FCS). The boundary between E and L
cells was set according to Hoffman et al. (refer-
ence 26) and as previously described (12). The
bracket indicates the percentages of L cells that
emerge after pre-TCR selection. Analyses are
representative for three individual sets of ani-
mals for each genotype. (B) Compiled data
from 11 WT or heterozygous (Gfi1 / ) and 11
Gfi1-deficient mice indicating L cell percent-
ages. A mean value and a standard deviation are
given. (C) Intracellular TCR  chain expression
levels in DN3 and DN4 subsets. Lin  thy-
mocytes were analyzed for expression of CD25
and CD44. The DN3 and DN4 subsets were
electronically gated to detect intracellular levels
of TCR . No difference could be found be-
tween normal thymocytes and those negative
for Gfi1.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
840 Altered Thymocyte Maturation in Gfi1 /  Mice
Disruption of Thymocyte Development in Gfi1-deficient Mice
Is Associated with Deregulated Expression of Potential Gfi1 Ef-
fector Genes. To identify potential downstream effector
genes of Gfi1, which could shed light on the role of Gfi1 in
T cell development, we used high density DNA microar-
rays to compare 11,000 murine genes for their expression
level in normal and Gfi1 /  mice. Two independent ex-
periments with RNA targets from pooled Gfi1 /  and WT
thymi and two independent experiments with FACS®-
sorted CD4 /CD8  DP cells from WT and Gfi1 /  mice
were performed. Evaluation of the array analysis and verifi-
cation by Northern blot and RT-PCR analysis led to the
identification of four genes that most prominently showed
up-regulated expression in Gfi1 /  total thymocytes or
Gfi1 /  DP cells compared with their WT counterparts
(Table I and Fig. 7 A). We found that the genes for the
bZIP transcription factor (c-Maf), the lung Krüppel-type
factor (LKLF), the adaptor protein TNFR-associated factor
(TRAF)5, and for the helix-loop-helix proteins Id1 and
Id2 were among those up-regulated in total Gfi1 /  thy-
mocytes (Table I and Fig. 7 A). Id3 expression appeared to
be unaffected by Gfi1 (Table I). TRAF5, LKLF, and the
genes for the helix-loop helix factors Id1 and Id2 were also
up-regulated in Gfi1 /  DP thymocytes (Table I and Fig. 7
B). The expression of the vast majority of other genes in-
cluding Pim-1, Notch, Ask-1 (Fig. 7 A), or members of the
Bcl-2 family (unpublished data) were unaffected by the loss
of Gfi1. Moreover, the experiments showed that Id1 ex-
Table I. Genes with Altered Expression Levels in Gfi-1    Thymocytes
Total thymocytes
Murine 11K array
Sorted CD4 /CD8  (DP) cells
Murine U74A array
Up-regulated in
Gfi-1    thymocytes
Fold change
(experiment 1)
Fold change
(experiment 2)
Fold change
(experiment 1)
Fold change
(experiment 2)
c-Maf 10.3 30.6 1.3 1.4
TRAF5 6.1 2.4 9.7 8.4
LKLF 3.6 2.9 8.3 10.2
Id1 absent absent 7.4 6
Id2 1.3 n.t. 4.2 3.5
Id3 absent absent 1.3 1.5
Total RNA was isolated from total thymocytes or from FACS®-sorted CD4 /CD8  cells of Gfi1 /  (Gfi1 / ) or WT animals and was used to
synthesize target cRNAs for the hybridization of four separate murine 11K DNA probe arrays and four separate U74A arrays (Affymetrix). The fold
change in expression levels in Gfi1 /  thymocytes or DP cells in relation to WT thymocytes or WT DP cells of two independent experiments for
each array set is shown. An average fold change of  2.5 was considered significant.
Figure 7. Expression of potential downstream effector
genes of Gfi1 in thymic T cells. (A) RNA from Gfi1 / 
( / ), Gfi1 heterozygous ( / ), or WT ( / ) animals
was analyzed after electrophoretic separation for the ex-
pression of TRAF5, c-Maf, Ask-1, LKLF, Pim-1, Notch,
as well as Id1 and Id2. The autoradiograms of a representa-
tive analysis are depicted. The level of TRAF5, c-Maf,
LKLF, and Id1-specific transcripts appears to be strongly
up-regulated in Gfi1 /  mice and Id2 transcripts appear to
be weakly up-regulated in cells lacking Gfi1. Expression
levels of Ask-1, Pim-1, or Notch 1 were not detectably al-
tered in Gfi1-deficient thymocytes compared with WT or
heterozygous controls. (B) Expression of Id1 and Id2 in
three different subsets of WT ( / ) or Gfi1-deficient
( / ) mice. CD8  and DN cells were isolated by mag-
netic beads and the DP cells were obtained by FACS® sort-
ing. Total RNA was isolated from the indicated thymic
subsets and was used for an RT-PCR reaction.T
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pression is also up-regulated in Gfi1 /  CD8 SP cells, how-
ever, the expression of both Id1 and Id2 appeared to be un-
affected in DN cells (Fig. 7 B). This suggests that Gfi1
negatively regulates these genes in particular thymocytes
subsets and that their expression is relieved from this re-
pression when Gfi1 is absent.
Discussion
The transcriptional repressor Gfi1 is expressed at very
high levels in thymic lymphoid cells compared with other
organs and cell Lins (3, 7, 12, 34, 45). Previous analyses
demonstrated that Gfi1 is present in DN and DP thy-
mocytes but is either absent or expressed at low levels in
the CD4 or CD8 SP cells (12), which suggested a role of
Gfi1 in early T cell development. Gfi1-deficient mice were
generated to shed more light on the role of this transcrip-
tion factor in these processes and pin down the develop-
mental stages where Gfi1 comes into action. The two most
prominent features of Gfi1 /  mice are a drastically re-
duced thymic cellularity and a significant bias toward the
production or selection of CD8 SP cells. This already dem-
onstrated that Gfi1 is generally required for a normal pro-
duction of T cell progenitors and their differentiation.
The most striking hallmark of Gfi1 /  animals, which is
certainly detrimental for T cell development, is the de-
creased thymic cellularity. The results from our analysis of
the early DN thymocyte subsets suggest that the decreased
number of cells in Gfi1 /  thymi is the consequence of on-
going apoptosis in c-Kit  cells and in particular in the DN1
and DN2 subpopulations that we could detect by annexin
V staining of the respective subpopulations. This correlates
not only with generally reduced DN cell numbers but also
with a depletion of c-Kit  cells in the DN (or Lin ) subset.
Hence, we propose that Gfi1 is responsible for the survival
or expansion of c-Kit  cells in the DN1 and DN2 subpop-
ulations. Further, our data suggest that the lack of Gfi1
blocks differentiation from DN1 to DN2 cells and there-
fore aggravates the depletion of the DN2 and following
subsets even more. This view is supported by the appear-
ance of a novel, very prominent, distinct population in
Gfi1 /  mice, which is Lin  and CD44hi CD25int. It is con-
ceivable that this novel population represents an accumula-
tion of intermediate cells, which are blocked on their way
from the DN1 to the DN2 stage. These cells are c-Kit ,
Thy1.2 , and also appear in fetal thymi of Gfi1 /  mice
except when they represent other, mature B or T cells im-
migrating from the periphery. Because in the WT thymus
cells of the DN2 population are proliferating and signifi-
cantly contribute to thymus size and cell numbers, their de-
pletion or reduction in the absence of Gfi1 due to apoptosis
may well explain the smaller thymus size and the low thy-
mic cellularity in Gfi1-deficient mice. In addition, the
newly arising CD44hi CD25int population is only slowly
proliferating. Provided that this population is a transitory
subset, this may present an additional reason for a delayed
development of DN2 from DN1 cells.
Our data support a role of Gfi1 in the same uncommitted
DN T cell progenitors (i.e., DN1 and DN2) that critically
depend on SCF and IL-7 (Fig. 5). Both SCF as well as IL-7
are expressed in Gfi1 /  mice (unpublished data) excluding
a lack of ligands as a cause for the observed perturbations in
the DN/c-Kit  population. The Gfi1 /  phenotype shares
some strikingly similar aspects with the phenotype of c-Kit–
(18) or IL-7R –deficient mice (21, 20, 46). The strong de-
pletion of c-Kit  cells or the down-regulation of c-Kit ex-
pression that is observed in DN1 and DN2 cells of Gfi1 / 
mice suggests that the observed phenotype in Gfi1null mice
is the consequence of a c-Kit deficiency. However, it can-
not be decided at present whether the loss of Gfi1 directly
affects either c-Kit or IL-7R pathways or parallel or down-
stream signaling events. It is not unlikely that Gfi1 is one
endpoint of c-Kit signaling and is required to translate the
physiological effects of c-Kit, namely survival and prolifera-
tion of T cell progenitors, or alternatively, that lack of Gfi1
interferes with a correct c-Kit expression. Our finding that
Bcl-2 was able to restore the loss of the c-Kit  cells but
failed to reconstitute a normal thymic cellularity in Gfi1 / 
mice suggests that Gfi1 is involved in both survival and pro-
liferation of c-Kit  T cells.
Our finding that the TRAF5 adaptor molecule is
strongly up-regulated in Gfi1-deficient thymocytes points
to the alternative possibility that costimulatory signals pro-
vided by members of the TNF family are affected by the
loss of Gfi1. It has been previously shown that TRAF5 is
involved in CD27, CD30, CD40, lymphotoxin   receptor,
and OX40 signaling and that overexpression of TRAF5
alone is sufficient for the subsequent activation of nuclear
factor  B and Jun kinase (47–49). The importance of these
pathways during the early T cell development is poorly un-
derstood but there is growing evidence for a function of
TNFR superfamily members in regulating apoptosis and
proliferation among DN thymocytes and during negative
selection (50, 51). The importance of death receptor signal-
ing in DN thymocyte development has been demonstrated
recently by constructing transgenic mice that express a
FADD dominant-negative mutant (52). It is possible that
the observed cell death phenotype of Gfi1 /  mice results
from interference with this type of signal.
We have previously suggested a role for Gfi1 in DN3
cells that was supported by earlier findings with transgenic
mice that express constitutively high levels of Gfi1 in pre-T
cells. In these animals a block at the E to L transition ex-
actly where pre-TCR selection occurs and an accumula-
tion of DN3 cells (12) is observed. In the Gfi1 KO mouse
we observe the opposite phenotype i.e., a higher propor-
tion of L cells than in WT controls. It is unclear how Gfi1
affects the pathways and regulatory mechanisms that con-
trol transition from DN3 to DN4 or from E to L cells
within DN3. Both Gfi1 overexpressing transgenic mice
and Gfi1 /  mice display a complete TCR repertoire (un-
published data) and in both types of mice an influence on
TCR  chain locus rearrangement could be excluded. In
particular, the lack of Gfi1 did not affect the production of
cytoplasmic or membrane-bound TCR  chains, suggestingT
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that Gfi1 is instead associated with processes that regulate
the cell size distribution among E and L cell subsets or the
expansion or survival of L cells than with the efficiency of
the VDJ recombination process (Fig. 6).
Another characteristic of Gfi1-deficient mice is the pre-
ponderance of CD8 SP cells with respect to CD4 SP cells.
We could exclude that the higher relative percentages of
CD8  cells in Gfi1 KO mice are due to an overrepresenta-
tion of CD8 ISP cells or their delayed development or are
the result of an increased proliferation of mature selected
CD8  cells. We suggest that Gfi1 plays a role in whether
DP cells differentiate into the CD4 or CD8 Lin and
thereby in the process of positive selection of DP cells.
This is supported by several findings in Gfi1 /  mice: first,
the general higher relative percentages of CD8  cells and
lower percentages of CD4  cells; second, the similar al-
tered ratio of CD4/CD8 percentages in CD69  and IL-
7R  thymocytes; and third, an apparently increased posi-
tive selection of MHC I–restricted HY-TCR–bearing
CD8  T cells.
According to a currently favored model, the efficient re-
cruitment of the tyrosine kinase Lck to the TCR and a
stronger Lck-mediated signal, resulting from TCR–MHC
class II interaction, promotes commitment to the CD4 Lin
whereas weaker Lck signals that are initiated after the TCR
interacts with MHC class I leads to development into CD8
Lin cells (53–55, for review see 42). Recently, an alterna-
tive so-called “kinetic signaling” model for CD4/CD8 Lin
determination and positive selection has been put forward
(56). Here, the Lin decision depends on the persistence and
not the strength of the Lck signal and CD4 cells are se-
lected from the DP pool upon a persistent TCR/MHC-
mediated signal (56). CD8   SP cells develop from a
CD4 CD8lo cell pool by a process termed coreceptor re-
versal upon cessation of the TCR signal (54). Interestingly,
in the kinetic signaling model, the coreceptor reversal and
the development toward the CD8 Lin is mediated by IL-
7R signaling (56). Because Gfi1 /   mice clearly have
higher relative numbers of DP/IL-7R   cells than WT
mice, this could explain the enhanced positive selection of
CD8  cells and the bias toward an overproduction of
CD8  cells in mice lacking Gfi1. However, we also found
that in Gfi1-deficient mice the CD4lo CD8lo cell pool that
is under selection contains more apoptotic cells than its
WT counterpart. The possibility exists that this alleviates
development of CD8  cells because positive selection of
CD8  cells might be more efficient when selectable thy-
mocytes are limiting.
Based on these models, we propose that Gfi1 might be
involved in the maintenance of a strong or persistent
TCR/MHC-mediated signal and suggest that the higher
relative percentages of CD8 SP cells and increased positive
selection in Gfi1-deficient mice is a consequence of a
weakened or shortened Lck signaling or a premature cessa-
tion of the Lck-mediated signals. We have observed that
during selection of DP cells, the relative percentage of
CD69  TCR hi cells is decreased in Gfi1 /  mice com-
pared with WT mice, although the same relative percent-
age of the preceding CD69  TCR lo population is not re-
duced. This argues for a signaling defect in Gfi1 /  mice
because up-regulation of TCR  during selection depends
on efficient TCR/MHC signal transduction (36). In addi-
tion, we found that CD4lo CD8lo and CD4  CD8lo popula-
tions in Gfi1 /  had a significantly lower proliferative po-
tential in the Gfi1null mice than in WT animals. These
subsets contain precisely those cells that are in the process
of positive/negative selection and Lin decision. Their
lower proliferation in the absence of Gfi1 may also reflect
a weaker signaling during selection with the result of a
preferred development of CD8  cells. Another argument
for a signaling defect in Gfi1 /  DP cells are their high
levels of LKLF. In WT cells, expression of the LKLF gene
is very efficiently down-regulated in cells that receive sig-
nals from TCR–MHC interactions (57). By contrast,
LKLF expression rises only in postselection SP cells after
that TCR/MHC signal has been completely shut off (57).
Hence, a premature appearance of LKLF in DP thy-
mocytes as is observed here is consistent with a lower or
absent TCR signaling.
How Gfi1 affects the strength or the duration of TCR/
MHC signaling remains to be clarified. We have previously
shown that the Gfi1 gene is an effector of TCR signaling
and is up-regulated shortly after stimulation of the TCR
with anti-CD3 antibodies in peripheral T cells (45). We
hypothesize that downstream effectors of Gfi1 might be
critical to maintain the signal to regulate the selection pro-
cess. Because one of the potential effectors of Gfi1, LKLF,
maintains the quiescent state of SP T cells and is quickly
down-regulated upon antigenic stimulation (57), it is con-
ceivable that constitutive high levels of LKLF, as seen in
Gfi1 /  cells, would counteract TCR-mediated signaling
events and as a consequence negatively affect selection and
Lin determination. More intriguingly, however, our find-
ing that the expression of the helix-loop-helix transcription
factors Id1 and Id2 is up-regulated in Gfi1 /  DP thy-
mocytes may offer an alternative explanation. Both mole-
cules are inhibitors of the E-box proteins E2A, E47, and
HEB (58). In particular, E47 and E1A deficiency has been
shown to accelerate positive selection and increase the per-
centage of CD8 SP cells (59). All of these features are also
observed in Gfi1 /  mice, strongly suggesting that Gfi1 ex-
erts these functions by acting as an upstream negative regu-
lator of Id1 and Id2 expression and subsequently of E-pro-
tein dosage. From this it appears likely that deficiency of
Gfi1 results in the relief of the repression of both Id pro-
teins and therefore to the inhibition of E-box protein func-
tion, among them possibly E2A and E47.
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